LENSAR Inc Total Liabilities
LENSAR Inc total liabilities. Based on the latest financial reports, LENSAR Inc (LNSR) has total liabilities worth $54.65 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LNSR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of LENSAR Inc (2018–2025)
Total liabilities of LENSAR Inc from 2018 to 2025. This chart illustrates how LENSAR Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of LENSAR Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
LENSAR Inc Competitors by Total Liabilities
The table below lists competitors of LENSAR Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sumeeko Industries Co Ltd
TWO:2066
|
Taiwan | NT$1.63 Billion |
|
Taiwan Alpha Electronic Co Ltd
TWO:6204
|
Taiwan | NT$157.31 Million |
|
Zakłady Lentex SA
WAR:LTX
|
Poland | zł93.79 Million |
|
Dynamic Medical Technologies
TWO:4138
|
Taiwan | NT$1.35 Billion |
|
Shanghai Lingang Holdings Co Ltd B
SHG:900928
|
China | $57.74 Billion |
|
Thai Mitsuwa Public Company Limited
BK:TMW
|
Thailand | ฿805.63 Million |
|
Unitronics
TA:UNIT
|
Israel | ILA58.52 Million |
|
Aero Win Technology Corp
TW:8222
|
Taiwan | NT$1.29 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down LENSAR Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LENSAR Inc assets under control.
Liquidity & Leverage Metrics
LENSAR Inc Total Liabilities Ratios Explained
LENSAR Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LENSAR Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LENSAR Inc (2018–2025)
The table below shows the annual total liabilities of LENSAR Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $97.45 Million | +104.51% |
| 2024-12-31 | $47.65 Million | +112.64% |
| 2023-12-31 | $22.41 Million | +61.68% |
| 2022-12-31 | $13.86 Million | +19.63% |
| 2021-12-31 | $11.59 Million | -2.72% |
| 2020-12-31 | $11.91 Million | -81.70% |
| 2019-12-31 | $65.09 Million | +31.89% |
| 2018-12-31 | $49.35 Million | -- |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies des… Read more